Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder.
about
A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHDEuropean consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDUnderstanding attention-deficit/hyperactivity disorder from childhood to adulthoodA review of the economic burden of ADHDAssociation between adult attention deficit/hyperactivity disorder and obesity in the US populationAssociation of pyrethroid pesticide exposure with attention-deficit/hyperactivity disorder in a nationally representative sample of U.S. childrenUpdate on environmental risk factors for attention-deficit/hyperactivity disorderIndividual and combined effects of physical exercise and methylphenidate on orienting behavior and social interaction in spontaneously hypertensive rats.Rate dependent effects of acute nicotine on risk taking in young adults are not related to ADHD diagnosisConnecting the dots: a review of resting connectivity MRI studies in attention-deficit/hyperactivity disorderThe role of anxiety symptoms in school performance in a community sample of children and adolescents.Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findingsPredictive validity of parent- and self-rated ADHD symptoms in adolescence on adverse socioeconomic and health outcomes.The impact of study design and diagnostic approach in a large multi-centre ADHD study. Part 1: ADHD symptom patternsThe validities and efficiencies of korean ADHD rating scale and korean child behavior checklist for screening children with ADHD in the community.Axis I psychopathology and the perpetration of intimate partner violence.Child abuse in group of children with attention deficit-hyperactivity disorder in comparison with normal children.Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trialsCognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder.The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative.Our current understanding of adult ADHDSelf-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group studyAttention-deficit/hyperactivity disorder and adverse health outcomes.Cognitive behavior therapy-based psychoeducational groups for adults with ADHD and their significant others (PEGASUS): an open clinical feasibility trialCost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysisWeight loss following a clinic-based weight loss program among adults with attention deficit/hyperactivity disorder symptoms.Psychometric properties of the quality of life scale Child Health and Illness Profile-Child Edition in a combined analysis of five atomoxetine trials.Sustained Attention Development during the Toddlerhood to Preschool Period: Associations with Toddlers' Emotion Regulation Strategies and Maternal BehaviorPatient characteristics, comorbidities, and medication use for children with ADHD with and without a co-occurring reading disorder: A retrospective cohort study.Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010.Attention deficit hyperactivity symptoms and risky sexual behavior in young adult women.The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Long-term consequences of childhood ADHD on criminal activities.Antisaccade-related brain activation in children with attention-deficit/hyperactivity disorder--A pilot study.Evaluation of children with ADHD on the Ball-Search Field Task.Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidateHippocampus and amygdala morphology in attention-deficit/hyperactivity disorder.Life impairments in adults with medication-treated ADHD.Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine.
P2860
Q21093202-D5C51788-D317-4DCF-BFD2-CED79C99817DQ21260332-F6BE68CF-4001-42D5-997E-22620EAF64ECQ22241209-A96480C4-57C8-4296-A466-468F3252D57FQ24815063-A4237D05-45BB-4781-BDFB-5252694A062BQ28306264-5FAB93EB-C9E1-4849-966D-7E63A1FDFB5AQ28395848-E8644D59-368A-49C0-81D5-5D13B01B34DBQ28396593-44C4B953-8014-4D12-95CD-59D1C2354D42Q30397085-3C58BBC4-86CF-49A0-B3E7-1AF133DFEDB5Q30532225-F18C505A-CE1D-45AF-A380-02AA00062B2AQ30748697-31EC9CF4-962A-458B-8F6B-72E6B87946FEQ33308342-3145BCB8-0AAD-426D-A218-8E368DCE196AQ33722315-1235D5FF-1F34-4606-A16A-D4BD2D739CEFQ33849674-0BC2C305-820A-4DD1-A8B4-99530DF404F3Q33865138-04CB3426-BC4D-4E22-ADAC-DFB061EBED24Q34012221-481659F9-6083-4435-AE5A-F76C671574A9Q34306968-61CC99EB-34F0-4EA9-ADEF-5ED6C9DECD62Q34360343-C467BC68-366C-4AD9-BF14-824A0CC2A01EQ34419671-B5908114-82CD-424D-AAC6-4791178B9001Q34447938-7A79F8C0-26B1-4A24-BC96-C1E39EE0EFC2Q34677931-A497DAA3-8589-4A3B-911D-A630453740B5Q34781993-D09EA62A-0870-4277-8B75-50AA241289AAQ34992295-FCAD77E3-3250-402B-AE59-A6EB9E73647BQ35012442-BA435413-836B-4304-80A8-928ADC4B64A0Q35065977-63949F97-3D48-480D-9CE7-F82D0E0F0C42Q35123043-EFBDF195-4EA3-4A1A-AE76-A18AF36C1AB4Q35252145-841C4C53-8D80-4DDA-9E0A-E04A268FBEA1Q35536129-28654CBE-6685-4A78-8BF2-28F792F523C2Q35563516-70927B9F-F49B-4DB5-AB32-5FDB3FDC5868Q35568623-6DA8CE7E-74CC-4F01-832E-E7D9A32EE085Q35682398-C64BB63E-1602-46F7-865D-4A8C00B1DCA3Q35840321-A34D8C09-9095-47FA-9CDB-4FF19114339EQ35876428-BC047943-C197-44EB-8F2E-3CA7C1F89723Q36058152-4B98088A-BE6C-43B0-83E3-D4A0C2C3EDCDQ36098336-07C6840A-EBA9-41F1-8323-42CCBFF5E2C5Q36330243-F151FAE0-9FC4-486E-B3F3-7669244E9B5DQ36500334-09357EF4-0DED-4507-9440-43A35B170364Q36526984-224DB4FB-DB9F-471B-8F01-35BE4FAACB76Q36632016-4480BC83-A139-4FA2-91A5-59748D3112B2Q36840424-CF75DD99-2FA8-4D9D-859B-91C88A72CA26Q36858837-56F7B2CC-136D-4B7F-BB8A-BACE33ABF950
P2860
Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Major life activity and health ...... eficit/hyperactivity disorder.
@ast
Major life activity and health ...... eficit/hyperactivity disorder.
@en
type
label
Major life activity and health ...... eficit/hyperactivity disorder.
@ast
Major life activity and health ...... eficit/hyperactivity disorder.
@en
prefLabel
Major life activity and health ...... eficit/hyperactivity disorder.
@ast
Major life activity and health ...... eficit/hyperactivity disorder.
@en
P1476
Major life activity and health ...... deficit/hyperactivity disorder
@en
P2093
Russell A Barkley
P478
63 Suppl 12
P577
2002-01-01T00:00:00Z